Eribulin in Brain Metastases From HER2-negative Breast Cancer

Clinical trial NCT03637868 · WITHDRAWN

Trial details

NCT number: NCT03637868
Sponsor: Institut Paoli-Calmettes
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2019-02-26
Primary completion: 2020-04-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.